Skip Navigation



Rheumatology Advance Access published online on July 28, 2006
Rheumatology, doi:10.1093/rheumatology/kel226
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
46/2/232    most recent
kel226v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goodall, J. C.
Right arrow Articles by Gaston, J. S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodall, J. C.
Right arrow Articles by Gaston, J. S. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received February 14, 2006
Accepted May 23, 2006

Original Papers

Does HLA-B27 influence the monocyte inflammatory response to lipopolysaccharide?

J. C. Goodall 1 *, L. Ellis 1, G. S. H. Yeo 2, and J. S. H. Gaston 1

1 Department of Medicine, School of Clinical Medicine, University of Cambridge, Addenbrookes Hospital, Cambridge CB2 2QQ, UK
2 Department of Clinical Biochemistry, Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK

* To whom correspondence should be addressed.
J. C. Goodall, E-mail: jcg23{at}medschl.cam.ac.uk


  Abstract

Objectives. How Human leucocyte antigen B27 (HLA-B27) contributes towards arthritis susceptibility is still unclear, but effects on the response to bacteria unrelated to the classical antigen presenting role of B27 have been suggested. This study investigated whether HLA-B27 modulates the innate response to lipopolysaccharide (LPS), a component shared between all Gram negative bacteria that can trigger reactive arthritis.

Methods. Pools of U937 transfectants expressing either HLA-B27, HLA-A2 or the expression plasmid alone were differentiated with phorbol 12-myristate 13-acetate (PMA) and stimulated with LPS. Supernatants were analysed for tumour necrosis factor-{alpha} (TNF-{alpha}) secretion and the gene expression profiles of unstimulated and LPS-stimulated cells were determined by microarray analysis. Changes in gene expression that are indicative of an unfolded protein response (UPR) were also analysed by quantitative polymerase chain reaction (PCR).

Results. TNF-{alpha} secretion, a biological marker of the inflammatory response to LPS, was not significantly different between U937-B27 and U937-control. No differences in gene expression between unstimulated U937-B27 and U937-control lines were detected. Both U937-control and U937-B27 exhibited a stereotypic response to LPS. Only one gene, OAS2, was differentially expressed by these cell lines, and this was confirmed by quantitative PCR. Analysis of XBP-1 splicing suggested that the UPR is induced following the LPS stimulation, but this increase was seen in all transfectants.

Conclusions. The expression of B27 does not profoundly alter the gene expression following LPS stimulation. Therefore, additional signals, such as those provided by cytokines or intracellular infection, may be required to reveal any influence of B27 expression on the inflammatory response.

Keywords: HLA-B27; Ankylosing spondylitis; U937; LPS; Unfolded protein response; Inflammation; Microarray.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.